Testing effectiveness (Phase 2)Ended earlyNCT00482625
What this trial is testing
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Who this might be right for
Intraductal Papillary Mucinous Neoplasm of the PancreasRecurrent Pancreatic CancerStage IA Pancreatic Cancer+4 more
National Cancer Institute (NCI) 6